GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CytoMed Therapeutics GDTC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.86

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

CytoMed Therapeutics annual report

Filed with the US Securities and Exchange Commission

20-F

The latest annual report covers the year to 31 Dec 2025, filed on 31 Mar 2026.

Read the 20-F on SEC.gov ↗

Five-year highlights

In SGD.

FY2025FY2024FY2023FY2022FY2021
RevenueSGD 319,201SGD 69,501SGD 509,125SGD 365,604SGD 84,178
Operating income−SGD 4.5m−SGD 3.1m−SGD 1.6m−SGD 2.3m−SGD 1.2m
Net income−SGD 3.9m−SGD 2.5m−SGD 4.1m−SGD 3.1m−SGD 2.1m
Free cash flow−SGD 4.4m−SGD 4.1m−SGD 3.6m−SGD 1.9m−SGD 2.3m
Total assetsSGD 8.0mSGD 10.1mSGD 12.4mSGD 5.3mSGD 6.1m
Shareholders' equitySGD 6.5mSGD 9.0mSGD 11.3mSGD 589,712SGD 2.6m

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.